1. Home
  2. PSFE vs VNDA Comparison

PSFE vs VNDA Comparison

Compare PSFE & VNDA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Paysafe Limited

PSFE

Paysafe Limited

SELL

Current Price

$5.72

Market Cap

290.3M

ML Signal

SELL

Logo Vanda Pharmaceuticals Inc.

VNDA

Vanda Pharmaceuticals Inc.

HOLD

Current Price

$4.31

Market Cap

301.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PSFE
VNDA
Founded
1996
2002
Country
United Kingdom
United States
Employees
N/A
N/A
Industry
Business Services
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
290.3M
301.1M
IPO Year
2020
2005

Fundamental Metrics

Financial Performance
Metric
PSFE
VNDA
Price
$5.72
$4.31
Analyst Decision
Hold
Strong Buy
Analyst Count
4
5
Target Price
$8.50
★ $11.75
AVG Volume (30 Days)
302.6K
★ 804.7K
Earning Date
11-12-2026
10-28-2026
Dividend Yield
N/A
N/A
EPS Growth
★ N/A
N/A
EPS
★ N/A
N/A
Revenue
N/A
★ $216,105,000.00
Revenue This Year
$6.51
$15.16
Revenue Next Year
$5.37
$35.50
P/E Ratio
N/A
★ N/A
Revenue Growth
N/A
★ 8.72
52 Week Low
$5.35
$4.27
52 Week High
$12.95
$9.91

Technical Indicators

Market Signals
Indicator
PSFE
VNDA
Relative Strength Index (RSI) 40.04 28.42
Support Level $5.35 N/A
Resistance Level $6.83 $5.37
Average True Range (ATR) 0.29 0.16
MACD 0.02 -0.04
Stochastic Oscillator 28.00 6.25

Price Performance

Historical Comparison
PSFE
VNDA

About PSFE Paysafe Limited

Paysafe Ltd is an integrated payments platform. Its core purpose is to enable businesses and consumers to connect and transact seamlessly through capabilities in payment processing, digital wallet, and online cash solutions. The company's reportable segments are Merchant Solutions and Digital Wallets. The Merchant Solutions segment, which derives maximum revenue, services markets in North America, Canada and Europe. The Digital Wallets segment services markets in Europe, UK, North America and Latin America. It derives a majority of revenue from the USA followed by Germany, the UK, and all other countries.

About VNDA Vanda Pharmaceuticals Inc.

Vanda Pharmaceuticals Inc is a biopharmaceutical company engaged in the development and commercialization of therapies to address high unmet medical needs and improve the lives of patients. Its commercial portfolio comprises three products; HETLIOZ for the treatment of Non-24-Hour Sleep-Wake Disorder (Non-24) & nighttime sleep disturbances in Smith-Magenis Syndrome (SMS); Fanapt for the treatment of schizophrenia; and PONVORY. Its other products include ASO Molecules, VQW-765, Tradipitant, and VTR-297. The maximum of revenue is derived from the Fanapt product sales. Geographically, the company sells its product predominantly in the United States, and also in Israel, Europe, and Canada.

Share on Social Networks: